In gastric cancer, for example, RPS13 has been reported to promote tumour cell growth and both RPS13 and RPL23 have been implicated in chemoresistance, although their value as independent prognostic markers for patient outcome remains to be clarified (Shi et al., 2004). This evidence concerns the gene RPS13 and neoplasm.